Migraine vs. Epilepsy: Overlap, Differences, and Comorbidity
Key Distinctions
| Feature | Migraine | Epileptic Seizure |
|---|---|---|
| Core phenomenon | Cortical spreading depression (CSD) + trigeminovascular activation | Abnormal hypersynchronous neuronal discharge |
| Headache | Central feature (moderate-severe, throbbing) | May occur post-ictally (post-ictal headache) |
| Duration | 4–72 hours (untreated) | Seconds to minutes (status epilepticus >5 min) |
| Consciousness | Preserved (except hemiplegic migraine, confusional migraine) | Often impaired (except focal aware seizures) |
| Motor phenomena | Rare (hemiplegic migraine) | Common: tonic-clonic, myoclonic, tonic, atonic |
| Aura | Gradual onset (5–60 min), positive visual/sensory/speech symptoms | Instantaneous; may be experiential (déjà vu, fear, epigastric rising) |
| EEG | Normal or nonspecific slowing | Ictal epileptiform discharges (not always captured) |
| Treatment | Triptans, gepants, CGRP mAbs, preventives | Antiseizure medications (ASMs), surgery, devices |
Comorbidity & Bidirectional Risk
- People with epilepsy: 2–3× higher migraine prevalence (~24% vs. 12% general).
- People with migraine: 2× higher epilepsy risk.
- Shared genetic susceptibility (CACNA1A, SCN1A, ATP1A2, PRRT2).
- Shared triggers: sleep deprivation, stress, alcohol, flashing lights.
Diagnostic Challenges
- Migralepsy: Seizure triggered by migraine aura (ICHD-3: "migraine aura-triggered seizure").
- Hemiplegic migraine vs. Todd's paresis: Both cause transient hemiparesis; history, EEG, genetics differentiate.
- Visual aura vs. occipital seizure: Aura = gradual, positive symptoms; seizure = instantaneous, often negative/forced deviation.
- Syncope vs. seizure vs. migraine: Provocation, prodrome, post-event state differ.
Shared Treatment Opportunities
- Topiramate, valproate: FDA-approved for both migraine prevention and epilepsy.
- CGRP mAbs: No seizure worsening signal; safe in comorbidity.
- Lifestyle: Sleep hygiene, stress management, trigger avoidance benefit both.
- Caution: Some ASMs worsen migraine (carbamazepine, phenytoin); some migraine meds lower seizure threshold (bupropion, high-dose tramadol).
Clinical Approach
- Detailed event history (witness account ideal).
- EEG (routine + sleep-deprived) if seizure suspected.
- MRI brain (epilepsy protocol) for structural lesions.
- Genetic panel if early onset, family history, or atypical features.
- Treat both conditions with compatible medications; monitor for interactions.
Migraine - Related Articles
- Shingles Pain and Itch Relief: Effective Treatments and What to Avoid
- Managing PMS Migraines: Causes, Relief & Treatment
- Cupping Therapy for Pediatric Migraines: Why Experts Advise Against It
- Migraine Aura and Post-Headache Confusion: When to Seek Medical Advice
- Can Butterbur Reduce Migraine Frequency?
- Percocet for Migraines: Why Opioids Are Not Recommended
- Wheat and Migraines: Understanding the Connection
